Human ACE2 Gene Replacement Mice Support SARS-CoV-2 Viral Replication and Nonlethal Disease Progression
ImmunoHorizons · 2024
DOI: 10.4049/immunohorizons.2400030 ↗Kurz gefasst
Fachartikel in der Zeitschrift ImmunoHorizons, 2024. Verfasst von Joshua M Thiede und 15 weiteren Autor:innen. Beteiligte Einrichtung: Center for Immunology, University of Minnesota Medical School, Minneapolis, MN. Hauptthemen laut MEDLINE: Angiotensin-Converting Enzyme 2, SARS-CoV-2, COVID-19, Virus Replication. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Many mouse models of SARS-CoV-2 infection involve expression of the human ACE2 protein, the entry receptor for SARS-CoV-2 Spike protein, in mouse tissues. However, most of these models suffer from nonphysiological regulation of ACE2 expression, which can lead to atypically severe infections and aberrant sites of viral replication. In this report, we developed and characterized an ACE2 gene replacement (ACE2-GR) mouse strain in which the mouse Ace2 genomic locus was replaced by the entire human ACE2 gene locus, and we investigated the ability of these animals to respond to SARS-CoV-2 infection. We show that ACE2-GR mice support SARS-CoV-2 viral replication, but, in stark contrast to the widely used K18-hACE2 transgenic model, this infection leads to a mild disease with no detectable involvement of the CNS. Thus, ACE2-GR mice provide a novel, to our knowledge, model to explore immune responses and long-term consequences of SARS-CoV-2 infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Immunology, University of Minnesota Medical School, Minneapolis, MN.
- Department of Medicine, University of Minnesota Medical School, Minneapolis, MN.
- Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, MN.
- Department of Veterinary Population Medicine, University of Minnesota College of Veterinary Medicine, St. Paul, MN.
ORCID-Profile: Joshua M Thiede, Jenna K Dick, Nicholas N Jarjour, Venkatramana D Krishna, Lily Qian, Jules Sangala, Orion Rainwater, Maxim C-J Cheeran, Stephen C Jameson, Geoffrey T Hart
Förderung
- NIAID NIH HHS
Zitieren
APA
Thiede, J. M., Dick, J. K., Jarjour, N. N., Krishna, V. D., Qian, L., Sangala, J., Benzow, K., Karanjeet, K., Chin, S., Rainwater, O., Cheeran, M. C., Hogquist, K. A., Jameson, S. C., Hart, G. T., Bold, T. D., & Koob, M. D. (2024). Human ACE2 Gene Replacement Mice Support SARS-CoV-2 Viral Replication and Nonlethal Disease Progression. ImmunoHorizons. https://doi.org/10.4049/immunohorizons.2400030
Vancouver
Thiede JM, Dick JK, Jarjour NN, Krishna VD, Qian L, Sangala J, et al. Human ACE2 Gene Replacement Mice Support SARS-CoV-2 Viral Replication and Nonlethal Disease Progression. ImmunoHorizons. 2024. doi:10.4049/immunohorizons.2400030
BibTeX
@article{Thiede2024,
author = {Thiede, Joshua M and Dick, Jenna K and Jarjour, Nicholas N and Krishna, Venkatramana D and Qian, Lily and Sangala, Jules and Benzow, Kellie and Karanjeet, Kul and Chin, Shine and Rainwater, Orion and Cheeran, Maxim C-J and Hogquist, Kristin A and Jameson, Stephen C and Hart, Geoffrey T and Bold, Tyler D and Koob, Michael D},
title = {Human ACE2 Gene Replacement Mice Support SARS-CoV-2 Viral Replication and Nonlethal Disease Progression},
journal = {ImmunoHorizons},
year = {2024},
doi = {10.4049/immunohorizons.2400030}
}
EUVIMED